Patent holdings for IPC class C07C 309/30

Total number of patents in this class: 282

10-year publication summary

24
22
30
26
30
32
15
19
19
5
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Intra-Cellular Therapies, Inc.
434
12
Journey Medical Corporation
96
9
Merck Sharp & Dohme LLC
3729
7
WisTa Laboratories Ltd.
130
6
BASF SE
21150
5
Shin-Etsu Chemical Co., Ltd.
5966
5
ChemoCentryx, Inc.
370
5
Gilead Sciences, Inc.
2189
5
Imago Biosciences, Inc.
40
5
Purdue Pharma L.P.
494
5
Shionogi & Co., Ltd.
863
5
Eidos Therapeutics, Inc.
20
5
Advansix Resins & Chemicals LLC
303
4
Apotex Inc.
201
4
Lantheus Medical Imaging, Inc.
168
4
Pharmatrophix, Inc.
23
4
Evonik Oxeno GmbH & Co. KG
360
4
Bristol-myers Squibb Company
4811
3
Uop LLC
4318
3
Chevron Oronite Company LLC
601
3
Other owners 179